GAMMA Investing’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.03K | Buy |
201
+63
| +46% | +$1.26K | ﹤0.01% | 3200 |
|
|
2025
Q1 | $2.72K | Buy |
138
+52
| +60% | +$1.02K | ﹤0.01% | 3316 |
|
|
2024
Q4 | $1.94K | Buy |
86
+20
| +30% | +$450 | ﹤0.01% | 3231 |
|
|
2024
Q3 | $1.69K | Buy |
66
+17
| +35% | +$434 | ﹤0.01% | 3117 |
|
|
2024
Q2 | $1.15K | Sell |
49
-4
| -8% | -$93 | ﹤0.01% | 3025 |
|
|
2024
Q1 | $932 | Buy |
53
+16
| +43% | +$281 | ﹤0.01% | 2958 |
|
|
2023
Q4 | $581 | Buy |
+37
| New | +$581 | ﹤0.01% | 2928 |
|